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Significance of nutrition in respiratory allergic
diseases: a review of scientific knowledge
Abstract
A significant increase in the occurrence of allergic respiratory diseases has
been perceived in the world in the last several decades. One of the presumed
causes of this phenomenon is the contemporary altered dietary pattern.
Many studies investigated the possible inflammatory or anti-inflammatory
effects of various nutrients in the pathophysiology of respiratory allergies.
Recent epidemiological studies reported an association between a high intake
of w-6 and a low intake of w-3 polyunsaturated fatty acids (PUFA-s) with
the elevated prevalence of respiratory allergies. w-6 PUFA-s are precursors
of strong inflammatory mediators which promote allergic inflammation,
whereas metabolites of w-3 PUFA-s are weak inflammatory mediators.
However clinical trials of w-3 supplementation failed to show substantial
beneficial results. A high dietary intake of salt could have a bronchocons-
trictive effect in the pathogenesis of asthma, whereas magnesium is consid-
ered to act bronchodilatatively, yet most research in asthmatic patients has
not proven these proposed impacts. Antioxidants, such as vitamin C, E, A,
flavonoides, isoflavones and some trace elements (selenium, zinc, manga-
nese, copper) are relevant in diminishing oxidative stress. Despite epidemio-
logical and some clinical evidence of a protective antioxidant effect against
the development of respiratory allergies, interventional studies mainly have
not confirmed significant benefit of antioxidant supplementation therapy.
Due to a large amount of controversial scientific evidence regarding the
possibility of preventing and treating respiratory allergies with a modified
diet, there is a need for further research in this field.
INTRODUCTION
Over the past 40 years there has been a dramatic increase in the pre-valence of allergic respiratory disease around the world (1). This
phenomenon, particularly present in industrial Western countries, is
considered to be the result of many environmental and lifestyle changes
of human population. Environmental changes include higher outdoor
(SO2, O3, NOx) and indoor (cigarette smoke) air pollution. Additional-
ly, the increased development of respiratory allergic diseases could
partly be a result of the lack of early childhood infections due to vacci-
nation, increase in hygiene, improvement in nutrition, overuse of anti-
biotics and decrease in family size (2). Recent findings emphasize that
lifestyle changes related to nutritional composition and dietary habits
could be strongly implicated in the observed elevated prevalence of al-
lergic asthma, allergic rhinitis and hay fever (1). The term Western diet
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altered in the composition of nutritional products in the
last five decades. Nutritional Western diet consists of ele-
vated consumption of refined sugars, fats and salt and a
reduced consumption of fresh fruit, vegetables, fresh fish
and red meat (3). Fresh fruit and vegetables are main
sources of vitamins, minerals and fiber content, while
fresh fish and red meat are important sources of antioxi-
dants such as selenium, zinc and copper (1, 3, 4). It is
presumed that an adequate diet rich in products that
contain substances with a beneficial impact on human
health could inhibit, arrest or even reverse the chain of
events in the pathophysiology of respiratory allergic dis-
eases. Substances with a protective effect against the risk
of respiratory allergy development are supposed to have
either anti-inflammatory or antioxidative characteristics.
w-3 polyunsaturated fatty acids and some trace elements
such as magnesium have been reported to have anti-in-
flammatory characteristics, whereas antioxidative pro-
tective effects are attributed to vitamins A, C, E, flavo-
noids, isoflavones and some trace elements (e.g. zinc,
manganese, selenium) (Table 1). A diet deficient in the
mentioned protective substances and/or a high dietary
intake of proinflammatory and prooxidative substances
could possibly increase individual susceptibility to ad-
verse environmental exposures such as allergens, infec-
tious agents and air pollution (4, 5, 6). Likewise, it has
been speculated in a number of scientific publications
that a high dietary intake of proinflammatory w-6 poly-
unsaturated acids or a consumption of products contain-
ing prooxidative agents, e.g. excessive levels of iron or
copper, increase the risk of developing allergic respira-
tory diseases (2).
This review will elaborate the dietary factors impor-
tant for the cause and prevention of respiratory allergy
and the possible aspects of therapy with dietary manipu-
lation in allergic respiratory diseases. Scientific results,
reviewed in this article, will be mostly based on epidemi-
ological studies such as cross-sectional, case-control and
longitudinal studies and on the reports of clinical studies
among patients with allergic respiratory disorders.
Polyunsaturated fatty acids:
w-6 versus w-3
Numerous scientific reports have assumed that the
consumption of essential polyunsaturated fatty acids is
related to the occurrence and severity of asthma, allergic
rhinitis and hay fever. Essential polyunsaturated fatty ac-
ids (PUFA-s) cannot be synthesized in the human or-
ganism and, since they are the compounds of phospholi-
pid membranes (7), they must be derived from nutrition.
Today’s Western diet contains less amounts of food prod-
ucts rich in saturated fat (lard, dairy fats) than before,
and they have been mostly replaced by food substances
abundant in w-6 PUFA-s (vegetable oils, margarine, meat).
This dietary shift, intended to reduce cardiovascular dis-
eases, simultaneously led to a decreased consumption of
food products rich in w-3 PUFA-s (oily fish, leafy vegeta-
bles) which are believed to have a beneficial impact on
human health (8, 9, 10). w-3 PUFA-s are reported to
have anti-inflammatory biological actions, whereas w-6
PUFA-s generally have pro-inflammatory actions and
therefore it is speculated that a modification in the amount
of these PUFA-s in nutrition could modulate the inflam-
matory process in allergic respiratory diseases. It has
been emphasized that the appropriate ratio of w-6/w-3
PUFA-s, and not the absolute higher intake of w-3 PUFA-s
could have beneficial impact on human health (11, 12).
Throughout the years researchers estimated that the diet
on which human beings evolved and their genetic pat-
terns were established had the ratio of w-6/w-3 PUFA-s
approximately 1/1 (11) whereas the ratio of w-6/w-3
PUFA-s in a typical Western diet is presumed to be 15/1
or even higher (12). Such extremely different ratios of
w-6 and w-3 PUFA-s of the past and present dietary
trends and the inappropriate amounts w-6 PUFA-s in to-
day’s nutrition are considered to be responsible for the
higher occurrence and development of respiratory aller-
gic diseases in our era (13). Furthermore, a recent review
on the importance of the appropriate ratio of w-6/w-3
PUFA-s in chronic diseases indicated eligible effects of
the 5/1 ratio on patients with asthma, whereas a ratio of
10/1 had adverse consequences (12).
w-6 and w-3 PUFA-s, integrated in the phospholipid
cell membranes, can be converted by various inflamma-
tory enzymes into metabolites with diverging inflamma-
tory potentials (Figure 1). Most commonly present w-6
PUFA in nutrition is linoleic acid (margarine, vegetable
oils). The consumed linoleic acid is desaturated and
elongated by enzymes into arachidonic acid (AA). AA is
a substrate for pro-inflammatory enzymes, cyclooxyge-
nases and lipoxygenases, which convert AA into various
highly active inflammatory mediators, such as 4-series
leukotrienes (LT4) and 2-series prostaglandins (PG2) (7,
14). In the pathophysiology of allergic diseases, espe-
cially asthma, LT4 play a major role by increasing vascu-
lar permeability, inducing chemotaxis of leukocytes, ac-
celerating the production of reactive oxygen species and
various cytokines, promoting bronchoconstriction and
mucus secretion (15). A specific prostaglandin PGE2 as a
proinflammatory mediator induces the activity of an in-
flammatory enzyme cyclooxygenase-2 and the production
of a pro-inflammatory cytokine IL-6 (16). Some research
indicates that PGE2 has immunomodulatory properties
on T- lymphocytes by promoting the TH2 phenotype
which plays a dominant role in the pathophysiology of
allergic diseases (8, 9, 17). However, there is some oppos-
ing evidence about PGE2 suggesting, additionally, its
antiinflammatory and bronchodilatative properties in the
lung (18). Conversely, a-linolenic acid, the most common
w-3 PUFA in the diet, is converted into eicosapentaenoic
acid (EPA) by the same series of enzymes (desaturases
and elongases) that are in charge of the synthesis of AA
from linoleic acid. The products of EPA’s enzymatic con-
version are 3-series prostaglandins (PG3), 5-series leuko-
trienes (LT5) and other inflammatory mediators which
possess low biological activity (7, 14). The chemotactic
potency of LT5 is 10–100 times lower than of LT4 (15)
while the bronchoconstrictive potency of LT5 is two
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times lower than of LT4 (19). In addition, prostaglandin
PGE3 much less induces cyclooxygenase-2 expression
and IL-6 secretion compared to PGE2 (16). Since a-lino-
lenic acid and linoleic acid compete for the same enzy-
matic substrate positions, it is evident that a-linolenic
acid competitively inhibits AA production and ultima-
tely reduces the synthesis of strong inflammatory media-
tors of AA conversion. In addition to that, EPA, the
a-linolenic metabolite, competes with AA as a substrate
for inflammatory enzymes and consequently directly in-
hibits the generation of AA metabolites (7, 13).
There is evidence that PUFA-s can also modulate the
activity of a transcription factor that plays a major role in
various inflammatory signaling pathways, nuclear factor
kB (NF-kB). It controls the expression of a variety of
genes which encode inflammatory mediators such as
cytokines, chemokines, adhesion molecules and inducible
effector enzymes (e.g. cyclooxygenase-2) (20). It is pre-
sumed that NF-kB is an important factor in the patho-
physiology of asthma (13) since there is some evidence
that macrophages of induced sputum and bronchial epi-
thelial cells from stable asthmatic patients have an in-
creased activity of NF-kB in comparison to healthy sub-
jects (21). It has been reported that w-3 PUFA-s inhibit
NF-kB activity directly by decreasing the degradation of
its inhibitory unit IkB (22, 23) and indirectly by decreas-
Period biol, Vol 111, No 1, 2009. 43
Significance of nutrition in respiratory allergies Ivana Saboli} Pipini} et al.
TABLE 1
Nutrients associated with allergic respiratory diseases*
Nutrients Dietary sources Mechanisams of effect
w-6 PUFA margarine, sunflower oil,
corn oil
– pro-inflammatory effect:
increases LT4 and PG2 production
w-3 PUFA oily fish, shellfish,
leafy vegetables
– anti-inflammatory effect:
decreases LT4 and PG2 production
Sodium salt – bronchoconstrictive effect




Zinc cereal grains, dairy products,
animal products
– antioxidant cofactor of SOD
Copper seafood, nuts, cereals,
legumes, dried fruits
– antioxidant cofactor of SOD
– in high quantities pro-oxidative effect
Manganese nuts, shellfish, soya,
dark chocolate
– antioxidant cofactor of SOD
Selenium seafood,
animal products
– antioxidant cofactor of glutathion peroxidase




Vitamin C fresh fruits and vegetables – antioxidant
– regenerates oxidized vitamin E
– anti-inflammatory effect
– bronchodilatative effect
Vitamin E eggs, vegetables,






liver, egg yolk, milk fat,
fish oils,
red, orange, green, and yellow fruits and vegetables
– antioxidants
Flavonoids apples, pears, red wine,
green, white and black tea, dark chocolate
– antioxidants







PUFA, polyunsaturated fatty acid; LT4, leukotriene 4; PG2, prostaglandin 2; SOD, superoxid-dismutase; DNA, deoxyribonucleic
acid. *Modified according to (4).
ing the production of AA metabolites which have been
demonstrated to activate NF-kB (24). In contrast, experi-
mental studies did not show increased activity of NF-kB
in the presence of EPA (24), and there is some evidence
that EPA decreases the endotoxin induced activation of
NF-kB in human monocytes (23). These observations
could explain EPA’s ability to reduce gene expression of
cyclooxygenases and inflammatory mediators via inhibi-
tion of the proinflammatory transcription factor NF-kB.
Increased dietary intake of w-3 rich products could there-
fore result in increased concentrations of these fatty acids
in phospholipid cellular membranes and consequently,
through the described mechanisms of the reduced in-
flammatory mediator production, lead to a beneficial,
antiinflammatory outcome (25). Epidemiological and
clinical studies confirmed these properties of PUFA-s,
indicating that serum IgE levels are positively associated
with w-6 PUFA-s and negatively with serum EPA levels
(26). Fish oil supplementation rich in w-3 PUFAs has
been shown to decrease the production of PGE2 (27),
LTB4 (28), and other pro-inflammatory mediators (29)
and to induce the production of LTB5 in inflammatory
cells (30). Likewise, another study demonstrated that
high daily EPA doses increase LT5 generation and reduce
AA, LT4 and PGE2 generation by polymorphonuclear
and mononuclear leukocytes in asthmatic patients (31).
The effect of w-6 and w-3 PUFA intake on the inci-
dence, prevalence and severity of respiratory allergic dis-
eases has been evaluated in a number of epidemiological
and interventional studies with controversial results. Many
epidemiological studies, mostly cross-sectional and case-
-control studies, reported positive association between a
high w-6 PUFA intake and a low w-3 PUFA intake, and
the prevalence, incidence or the severity of asthma (9, 32,
33), and allergic rhinitis (34, 35, 36) in children (37) and
adults. On the other hand, a number of population stud-
ies reported no association between increased consump-
tion of w-3 and the risk of allergic respiratory disease (38,
39, 40).
A significant protective role of w-3 PUFA-s in the inci-
dence and severity of respiratory allergy symptoms was
reported in a prospective study only for children (41).
Therefore, there is a presumption that increased w-3
PUFA intake in early childhood could lead to a protective
effect of w-3 PUFAs which extends into later life (41).
This observation could encourage the recommendation
for increased consumption of products rich in w-3 in
early childhood.
A number of reported clinical trials regarding the ef-
fect of w-3 PUFA-s on the severity of allergic respiratory
disorders has also had controversial results. There are
studies with disappointing outcomes and no evidence for
recommendation of w-3 PUFA-s as a dietary supplement
(42, 43, 44). These studies failed to show clinical benefit
of w-3 PUFA or EPA supplementation, but they were
able to show a substantional suppression of neutrophil
chemotaxis and leukotrien production in treated patients
(42, 43). On the contrary, some studies found the evi-
dence of a clinical benefit in asthmatic patients following
w-3 PUFA supplementation due to the positive effect on
lung function, decreased bronchial hyperreactivity, de-
creased concentrations of airway inflammation markers
in exhaled air, and decreased reported daytime wheeze
(45, 46, 47). The studies of Okamota (45, 46) also suggest
that asthmatic patients differently manifest susceptibility
for a positive w-3 effect which was speculated to be genet-
ically predisposed (12). This assumption emerged from the
observation that w-3 PUFA supplementation differently
modified the leukotrien profile among asthmatic pa-
tients (46).
Electrolytes: Sodium & Magnesium
Certain substances in nutrition that are implicated in
the development of allergic respiratory diseases, particu-
larly asthma, are sodium and magnesium. These miner-
als have opposing effects on the airway smooth muscle
cells and it has been postulated that a diet rich in sodium
and low in magnesium could be a risk factor for airway
allergic diseases (2, 6, 17).
Sodium. It appears that individuals with airway hyper-
responsiveness have an increased sodium influx into air-
way smooth muscle cells resulting in their sustained
hyperpolarization. This increased level of hyperpolari-
zaton could contribute to the airway hiperreactivity to
specific antigen stimuli in asthma (17, 49). There is evi-
dence that a diet rich in sodium could predispose the de-
velopment of allergic airway hyperreactivity (50, 51, 52),
yet research has not provided conclusive proof that so-
dium restriction improves asthma (17, 53, 54).
Magnesium. Magnesium maintains a stable electric
potential across cell membranes and inhibits colinergic
neuromuscular transmission and therefore could have a
direct relaxing effect on bronchial smooth muscle, pro-
ducing airway dilatation (17, 55, 56). Magnesium also
has antiinflammatory and indirect bronchodilatative pro-
perties by stabilizing mast cells and T-lymphocytes, and
stimulating the generation of nitric oxide and prosta-
cyclin (56). Reported population studies provide eviden-
ce of a protective role of magnesium against asthma (6)
but placebo-controlled trials of magnesium supplemen-
tation have not confirmed beneficial results (57, 58).
Antioxidants
Oxidative stress is considered to play a substantial role
in the pathophysiology of respiratory allergic diseases (2,
59). Oxidative stress arises when the production of reac-
tive oxygen species (ROS) exceeds the capacity for their
elimination. Reactive oxygen species such as superoxide
radical (O2·), hydroxyl radical (OH·) and hydrogen per-
oxide (H2O2) contain oxygen atoms with one or more
unpaired electrons, generated by either endogenous or
exogenous sources. Endogenous production of ROS is
mostly derived from aerobic metabolism or inflamma-
tion in the organism. Exogenous ROS (NOx, O3) emerge
in the tissue of the respiratory system from polluted air,
e.g. cigarette smoke. ROS promote the inflammatory
process by inducing the release of proinflammatory me-
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diators (cytokines, chemokines, eikosanoid metabolites)
and activating gene expression of primal inflammatory
regulators such as nuclear factor kB (60).
Oxidative stress is mitigated by enzymatic and non-
enzymatic scavenging mechanisms of ROS. Enzymatic
antioxidant defense consists of three main groups of en-
zymes: 1) superoxide dismutases (SOD), 2) catalases
(CAT), 3) glutathion peroxidases. Some of these anti-
oxidative enzymes, specifically superoxide dismutases
and glutathion peroxidases, need cofactors for their ac-
tivity. Zinc (Zn), copper (Cu) and manganese (Mn) are
cofactors of two types of superoxide dismutases, Cu/Zn-
SOD and Mn-SOD, while selenium (Se) is the cofactor
of gluthation peroxidases (2). These cofactors are derived
from various nutritional products in the diet. Additional
elimination of ROS is accomplished by extracellular
non-enzymatic antioxidants which includes vitamins C,
E, A and carotenoids together with flavonoids and iso-
flavones (2, 4, 5). The above mentioned antioxidative
agents (cofactors, vitamins, flavonoids and isoflavones)
diminish oxidative stress either through common mech-
anisms or unique functions which include antiinflamma-
tory properties. Since these enzymatic and non-enzymatic
antioxidants are mostly derived from various nutritional
substances, the possibility of modifying oxidative stress
and by it allergic inflammation with a particular dietary
intake has been widely studied.
Enzymatic antioxidants
Zinc, copper and manganese. Superoxid dismutases
(Cu/Zn-SOD and Mn-SOD) are intracellular or extra-
cellular scavangers of ROS, and a dietary deficiency in
their cofactors, Zn, Cu or Mn could diminish SOD activ-
ity and therefore decrease antioxidant protection. Zinc,
besides its antioxidant properties as a cofactor, has the
ability to displace redox active iron which promotes oxi-
dative stress from macromolecular binding sites (2, 61).
Therefore a high dietary intake of iron and a low intake
of zinc could enhance oxidative damage and possibly in-
crease the risk of allergic respiratory diseases. Furthermore,
there is evidence that zinc has specific anti-inflammatory
properties due to the findings that a Zn deficiency could
be a trigger for NF-kB activation (62). Copper, in spite of
its antioxidative role as an enzyme cofactor, is a powerful
redox active transition metal and therefore high intake of
Cu (contaminated drinking water) should be considered
as a possible risk for asthma (2). One study evaluated
plasma Se, Mn, Cu, and Zn concentrations in asthmatic
patients and healthy subjects, reporting lower levels of
only Mn in asthmatic subjects compared to healthy sub-
jects (63). To our knowledge, dietary supplementation of
these trace elements in patients with allergic respiratory
diseases has not been studied except for one study con-
cerning the supplementation of Zn in asthmatic subjects
which showed no beneficial results (64).
Selenium. Selenium, as a cofactor of gluthation per-
oxidase, achieves its antioxidative effects by reducing
lipid peroxidation, scavenging free radicals, detoxicating
toxic metals and regenerating damaged DNA (4). It ap-
pears that selenium also exhibits immunomodulatory
properties by promoting TH1 lymphocyte cytokine secre-
tion and possibly inhibiting the secretion of TH2 cytokines
(65). Additionally, selenium expresses anti-inflamma-
tory and antiallergic properties by inhibiting the activa-
tion of the nuclear factor kB (66), and modulating archido-
nic acid metabolism which includes reducing the synthesis
of leukotrien4 (2). A recent study suggested that serum Se
levels and the prevalence of atopy had an inverse associa-
tion (67). Additionally, other epidemiological studies re-
ported lower serum levels of Se and glutathion peroxidase
activity in asthmatic subjects compared to non-asthmatic
subjects (4, 63, 68) and also reported that a higher dietary
selenium intake was related to a lower prevalence of
asthma (69). Even some clinical trials indicated benefi-
cial properties of Se in asthmatic patients reporting that
supplementation of Se resulted in the improvement of
asthma symptoms (70) and in the reduction of cortico-
steroid therapeutic dose (71).
Non-enzymatic antioxidants
Vitamin C. Vitamin C, a water soluble vitamin, is an
abundant antioxidant in the respiratory tract lining fluid
where it majorly contributes to the endogenous and ex-
ogenous elimination of ROS (72). Vitamin C has a pro-
minent role in the regeneration of membrane-bound ox-
idized vitamin E (73). It has been reported that vitamin
C may be useful for prevention of lung oxidant injury not
only as an oxidant scavenger but also as an inhibitor of
polymorphonuclear leukocyte influx to the pulmonary
tissue (74). Additionally, vitamin C appears to prevent
the secretion of histamine by leukocytes and increase its
degradation (75). The antagonistic effects of vitamin C
on prostangladin F2a-induced bronchoconstriction have
been reported in an experimental study (17). There is
ample published literature on vitamin C and allergic re-
spiratory diseases. Most population studies (cross-sec-
tional and case-control) that evaluated the relation be-
tween different values of vitamin C intake or serum
ascorbic acid levels with parameters of respiratory func-
tion or reported respiratory symptoms showed a benefi-
cial effect of vitamin C on the prevalence and severity of
symptoms in asthma (76, 77) and indicated that plasma
and leukocyte vitamin C concentrations are significantly
lower in individuals with asthma than in healthy subjects
(78). However, the only prospective study found no effect
of vitamin C on the incidence of asthma (40). Clinical
trials have shown inconsistent results regarding the effect
of vitamin C on the severity of respiratory allergic dis-
eases. These studies usually involved a small group of
subjects and short term administration of vitamin C.
There are studies reporting that ascorbic acid supple-
mentation in asthmatic patients reduces airway hiperre-
activity (79) or decreases the severity of asthmatic attacks
(80) and in combination with vitamin E protects against
ozone-induced bronchoconstriction (81, 82). Effective
vitamin C therapy has been reported in patients with pe-
rennial allergic rhinitis (83, 84). However, the evidence
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of positive effects of vitamin C in asthmatic patients has
not been verified in majority of studies (57, 80, 85).
Vitamin E. Vitamin E is a lipid soluble vitamin and a
potent dietary antioxidant in the pathophysiology of al-
lergic respiratory diseases (2, 4). Antioxidative mecha-
nism of vitamin E is achieved by protecting lipid cell
membranes against oxidative stress. In addition, vita-
min E appears to have immunomodulatory effects pro-
moting TH1 differentiation (86, 87, 88) and antiallergic
properties since there is evidence that a high intake of vi-
tamin E is inversely associated with allergic sensitiza-
tion and IgE serum levels (88, 89). Epidemiological
studies reported that vitamin E intake is associated with
a reduced asthma incidence and prevalence (40, 77) and
in the combination with vitamin C appears to protect
against ozone induced asthma (81, 82). However,
supplementation of vitamin E in asthmatic patients did
not reveal any clinical benefit (90).
Vitamin A & carotenoids. Vitamin A and carotenoids
are lipid soluble antioxidants which diminish lipid per-
oxidation and scavenge superoxide radicals (4). In epi-
demiological studies dietary vitamin A and carotenoid
intake and serum retinol levels were positively associated
with ventilatory function of asthma patients (91) and in-
versely correlated with the prevalence of adult asthma
(92) and the severity of asthma symptoms (93, 94). Addi-
tionally, high plasma carotenoid concentration is sug-
gested to have a protective effect on allergic rhinitis in
adulthood (95). However, clinical trials investigating the
effect of vitamin A on allergic respiratory diseases have
been scarce and reported limited beneficial results (96).
Flavonoids & isoflavones. Flavonoids are hydrosoluble
scavengers of ROS and lipid peroxyl radicals (4). Their
antioxidative role is also reflected in inhibiting prooxida-
tive enzymes and acting as chelators of toxic metals (4,
97). In addition to antioxidative effects, flavonoids are
supposed to be immunomodulatory and antiallergic agents.
Immunomodulatory properties are exhibited by the pro-
motion of TH1 lymphocyte differentiation (98, 99) whe-
reas antiinflammatory effects are achieved by the inhibi-
tion of nuclear factor kB activity (100). There is evidence
that flavonoids have protective effects on the incidence
and prevalence of asthma (97, 101). Epidemiological stu-
dies have showed that high intake of apples and pears
lowered the risk of asthma, while red wine consumption
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Figure 1. Metabolism of w-6 and w-3 PUFA-s and biosynthesis of inflammatory mediators. Legend: »+« indicates activation; »-« indicates inhibition.
was negatively associated with asthma severity. The pro-
tective effects in apples, pears and red wine were pre-
scribed to flavonoids which are abundant in these prod-
ucts (69, 101, 102). However, it should be regarded that
the protective effect of fresh fruits reported in these epi-
demiological studies could actually be provided from the
combining effect of various antioxidative agents that are
abundant in these nutritional products (69).
Recent research on isoflavones, known for their estro-
genic characteristics, reported antioxidative and antiin-
flammatory properties (103) which could explain their
ability to reduce the prevalence and severity of respira-
tory allergic symptoms found in epidemiological studies
(104, 105).
CONCLUSION
Currently, there is a significant amount of epidemio-
logical evidence supporting the idea of a preventive effect
of w-3 PUFA-s, magnesium and antioxidants against the
development of allergic respiratory diseases in adults.
However, controversial results of w-3 or antioxidant the-
rapy and disappointing results of magnesium supple-
mentation in the conducted clinical trials show a possible
complex association of these dietary nutrients and aller-
gic respiratory disorders. There is lacking evidence to
recommend w-3 PUFA-s as adjuvant therapy except in
identified genetically predisposed individuals who could
possibly benefit from such supplementation. On the other
hand, disappointing results of antioxidant therapy in
clinical trials could be interpreted by the presumption
that the protective effect of antioxidants emerges from
their combination in nutrition, and therefore supplemen-
tation of one specific antioxidant would be pointless.
Based on the reported scientific data in this review we
can conclude that, due to controversial evidence, the con-
cept of preventing and treating respiratory allergies with
a modified diet needs further clarification and investiga-
tion.
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